Teyi Pharmaceutical Group Co Ltd (002728) — Strategic Asset Allocation Index
Teyi Pharmaceutical Group Co Ltd (002728) has a Strategic Asset Allocation Index of 46.9% as of June 2023. Strategic assets (PP&E of CN¥660.23 Million plus long-term investments of CN¥-) total CN¥660.23 Million, measured against net assets of CN¥1.41 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 002728 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Teyi Pharmaceutical Group Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Teyi Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 46.9%, representing strategic assets of CN¥660.23 Million against net assets of CN¥1.41 Billion CNY. For live market cap and overall valuation, see 002728 market cap.
Annual Strategic Asset Allocation Index for Teyi Pharmaceutical Group Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Teyi Pharmaceutical Group Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002728 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 47.7% | CN¥601.68 Million | CN¥601.68 Million | CN¥- | CN¥1.26 Billion | ▼ -3.6 pp |
| 2020 | 51.3% | CN¥554.23 Million | CN¥554.23 Million | CN¥- | CN¥1.08 Billion | ▲ +6.0 pp |
| 2019 | 45.3% | CN¥522.72 Million | CN¥522.72 Million | CN¥- | CN¥1.15 Billion | ▲ +2.0 pp |
| 2018 | 43.3% | CN¥481.01 Million | CN¥481.01 Million | CN¥- | CN¥1.11 Billion | ▼ -0.6 pp |
| 2017 | 43.9% | CN¥457.75 Million | CN¥457.75 Million | CN¥- | CN¥1.04 Billion | ▲ +4.4 pp |
| 2016 | 39.5% | CN¥349.92 Million | CN¥349.92 Million | CN¥- | CN¥886.57 Million | ▲ +3.2 pp |
| 2015 | 36.3% | CN¥291.61 Million | CN¥291.61 Million | CN¥- | CN¥804.30 Million | ▲ +20.8 pp |
| 2014 | 15.5% | CN¥113.84 Million | CN¥113.84 Million | CN¥- | CN¥735.64 Million | ▼ -17.8 pp |
| 2013 | 33.3% | CN¥116.67 Million | CN¥116.67 Million | CN¥- | CN¥350.14 Million | ▲ +16.4 pp |
| 2012 | 17.0% | CN¥48.37 Million | CN¥48.37 Million | CN¥- | CN¥285.34 Million | ▲ +0.3 pp |
| 2011 | 16.6% | CN¥37.49 Million | CN¥37.49 Million | CN¥- | CN¥225.51 Million | — |